Page last updated: 2024-11-03

procaine and Squamous Cell Carcinoma of Head and Neck

procaine has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Procaine: A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016).
procaine : A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol.

Squamous Cell Carcinoma of Head and Neck: The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bhol, CS1
Mishra, SR1
Patil, S1
Sahu, SK1
Kirtana, R1
Manna, S1
Shanmugam, MK1
Sethi, G1
Patra, SK1
Bhutia, SK1

Other Studies

1 other study available for procaine and Squamous Cell Carcinoma of Head and Neck

ArticleYear
PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma.
    Biochimica et biophysica acta. Molecular basis of disease, 2022, 09-01, Volume: 1868, Issue:9

    Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA; Head and Neck Neoplasms; Humans; Methyltra

2022